Inhibitor Therapeutics, Inc. Deferred Offering Costs
Inhibitor Therapeutics, Inc. (INTI) had Deferred Offering Costs of $10.00 thousand as of 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2014-10-10
- 2014-03-31: Deferred Offering Costs $10.00K.
- 2013-12-31: Deferred Offering Costs $10.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2014-03-31 | $10.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $10.00K 10-Q · filed 2014-10-10 |